|
Lantern Pharma Inc (NASDAQ: LTRN) |
|
Lantern Pharma Inc
LTRN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Lantern Pharma Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Lantern Pharma Inc net loss decreased from $-5 millions, to $-5 millions in III. Quarter 2024,
• More on LTRN's Growth
|
|
Lantern Pharma Inc realized a net loss in trailing twelve months.
Lantern Pharma Inc realized cash reduction of $ -1.94 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
• More on LTRN's Valuation
|
|
|
|
|
Lantern Pharma Inc realized net loss in trailing twelve months.
Lantern Pharma Inc realized cash outflow of $ -1.94per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.03.
Lantern Pharma Inc Price to Book Ratio is at 1.42 lower than Industry Avg. of 79.3. and higher than S&P 500 Avg. of 0.01
• More on LTRN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com